Learn from antibody–drug conjugates: consideration in the future construction of peptide-drug conjugates for cancer therapy
Abstract Cancer is one of the leading causes of death worldwide due to high heterogeneity. Although chemotherapy remains the mainstay of cancer therapy, non-selective toxicity and drug resistance of mono-chemotherapy incur broad criticisms. Subsequently, various combination strategies have been deve...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMC
2022-11-01
|
| Serier: | Experimental Hematology & Oncology |
| Fag: | |
| Online adgang: | https://doi.org/10.1186/s40164-022-00347-1 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|